HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination

Vaccine

Volumn 26, Issue 27-28, 2008, Pages 3414-3420

  Lin, Hans Hsienhong ^a,b   Liao, Huei Wen Chang ^a   Lin, Sheng Kai ^a   Wang, Li Yu ^a,c  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adolescent; HBV vaccine; Immune memory; Revaccination

Indexed keywords

HAVACB; HEPATITIS B SURFACE ANTIBODY; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ANTIGEN EXPRESSION; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HAPLOTYPE; HEPATITIS B; HLA SYSTEM; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL;

ADOLESCENT; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HLA ANTIGENS; HUMANS; IMMUNIZATION, SECONDARY; MALE; NUCLEIC ACID HYBRIDIZATION;

EID: 44749084928     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.04.038     Document Type: Article

References (35)

1. Chen D.S., Hsu N.H., Sung J.L., Hsu T.C., Hsu S.T., Kuo Y.T., et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 257 (1987) 2597-2603
2. Whittle H.C., Inskip H., Hall A.J., Mendy M., Downes R., and Hoare S. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Lancet 337 (1991) 747-750
3. Da Villa G., Picciottoc L., Elia S., Peluso F., Montanaro F., and Maisto T. Hepatitis B vaccination: universal vaccination of newborn babies and children at 12 years of age versus high risk groups. A comparison in the field. Vaccine 13 (1995) 1240-1243
4. Chen H.L., Chang M.H., Ni Y.H., Hsu H.Y., Lee P.I., Lee C.Y., et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 276 (1996) 906-908
5. Chang M.H., Chen C.J., Lai M.S., Hsu H.M., Wu T.C., Kong M.S., et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 336 (1997) 1855-1859
6. Hsu H.M., Lu C.F., Lee S.C., Lin S.R., and Chen D.S. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass vaccination. J Infect Dis 179 (1999) 367-370
7. Lin H.H., Wang L.Y., Hu C.T., Huang S.C., Huang L.C., Lin S.S., et al. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol 69 (2003) 471-474
8. Lu S.N., Chen C.H., Chen T.M., Lee P.L., Wang J.H., Tung H.D., et al. Hepatitis B virus infection in adolescents in a rural township-15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 24 (2006) 759-765
9. Lin H.H., Wu J.S., Lu C.F., Wong C.K., and Hepatitis. B virus infection among aboriginal children in eastern Taiwan. J Formos Med Assoc 91 (1992) 691-693
10. Department of Health. Health and Vital Statistics, Republic of China. Department of Health, Executive Yuan, Republic of China; 2004.
11. Wu J.S., Hwang L.Y., Goodman K.J., and Beasley R.P. Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis 179 (1999) 1319-1325
12. Lu C.Y., Chiang B.L., Chi W.K., Chang M.H., Ni Y.H., Hsu H.M., et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 40 (2004) 1415-1420
13. Coursaget P., Leboulleux D., Soumare M., le Cann P., Yvonnet B., Chiron J.P., et al. Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. J Hepatol 21 (1994) 250-254
14. Viviani S., Jack A., Hall A.J., Maine N., Mendy M., Montesano R., et al. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine 17 (1999) 2946-2950
15. Hsu H.Y., Chang M.H., Liaw S.H., Ni Y.H., and Chen H.L. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30 (1999) 1312-1317
16. Kato H., Nakata K., Hamasaki K., Hida D., Ishikawa H., Aritomi T., et al. Long-term efficacy of immunization against hepatitis B virus in infants at high-risk analyzed by polymerase chain reaction. Vaccine 18 (2000) 581-587
17. McMahon B.J., Bruden D.L., Petersen K.M., Bulkow L.R., Parkinson A.J., Nainan O., et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 142 (2005) 333-341
18. Wang L.Y., and Lin H.H. Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago. Vaccine 25 (2007) 7160-7167
19. Thursz M.R., Kwiatkowski D., Torok M.E., Allsopp C.E., Greenwood B.M., Whittle H.C., et al. Association of hepatitis B surface antigen carriage with severe malaria in Gambian children. Nat Med 1 (1995) 374-375
20. Hohler T., Gerken G., Notghi A., Lubjuhn R., Taheri H., Protzer U., et al. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol 26 (1997) 503-507
21. Ahn S.H., Han K.H., Park J.Y., Lee C.K., Kang S.W., Chon C.Y., et al. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 31 (2000) 1371-1373
22. Thio C.L., Thomas D.L., Karacki P., Gao X., Marti D., Kaslow R.A., et al. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 77 (2003) 12083-12087
23. Wu Y.F., Wang L.Y., Lee T.D., Lin H.H., Hu C.T., Cheng M.L., et al. HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan. J Med Virol 72 (2004) 17-25
24. McDermott A.B., Zuckerman J.N., Sabin C.A., Marsh S.G., and Madrigal J.A. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 50 (1997) 8-14
25. Desombere I., Willems A., and Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens 51 (1998) 593-604
26. Wang C., Tang J., Song W., Lobashevsky E., Wilson C.M., and Kaslow R.A. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 39 (2004) 978-988
27. Mineta M., Tanimura M., Tana T., Yssel H., Kashiwagi S., and Sasazuki T. Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans. Int Immunol 8 (1996) 525-531
28. Qian Y., Zhang L., Liang X.M., Hou J.L., and Kuo K.X. Association of immune response to hepatitis B vaccine with HLA-DRB1*02, 07, 09 genes in the population of Han nationality in Guangdong Province. Di Yi Jun Yi Da Xue Xue Bao 22 (2002) 67-69
29. Hohler T., Reuss E., Evers N., Dietrich S., Rittner C., Freitag C.M., et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 360 (2002) 991-995
30. Roome A.J., Walsh S.J., Cartter M.L., and Hadler J.L. Hepatitis B vaccine responsiveness in Connecticut public safety personnel. JAMA 270 (1993) 2931-2934
31. Wood R.C., MacDonald K.L., White K.E., Hedberg C.W., Hanson M., and Osterholm M.T. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 270 (1993) 2935-2939
32. Hsu L.C., Lin S.R., Hsu H.M., Chao W.H., Hsieh J.T., Wang M.C., et al. Ethnic differences in immune responses to hepatitis B vaccine. Am J Epidemiol 143 (1996) 718-724
33. Alimonos K., Nafziger A.N., Murray J., and Bertino Jr. J.S. Prediction of response to hepatitis B vaccine in health care workers: whose titers of antibody to hepatitis B surface antigen should be determined after a three-dose series, and what are the implications in terms of cost-effectiveness?. Clin Infect Dis 26 (1998) 566-571
34. Martinetti M., De Silvestri A., Belloni C., Pasi A., Tinelli C., Pistorio A., et al. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol 97 (2000) 234-240
35. Wang L.Y., and Lin H.H. Ethnicity, substance use, and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination. J Hepatol 46 (2007) 1018-1025